Efficacy and Safty Analysis of Low-Energy X Ray IORT in the Treatment of Resectable Pancreatic Cancer

Di Sun,Xu Liu,Wei Dong,Qian Zhang,Yubao Zhang,Chunbo Zhao
DOI: https://doi.org/10.21203/rs.3.rs-3951098/v1
2024-01-01
Abstract:Abstract Objective: This study was to investigate the safety and the efficacy of low-energy X-ray intraoperative radiotherapy(LEX-IORT) in the clinical treatment of resectable pancreatic cancer. Method: We retrospectively analyzed the clinical information of the 88 patients with resectable pancreatic cancer in our hospital from 2011 to 2018. According on postoperative adjuvant regimen, The patients were divided into four subgroups. Chi-square test was used to analyze survival among subgroups. Kaplan-Meier method was used to estimate the survival rate. meanwhile, we compared complications, acute and chronic radiation injury, adverse reactions. P<0.05 was considered statistically significant. Result: Group A: 14 patients, Only operation; Group B: 25 patients, Surgery+postoperative chemotherapy; Group C: 28 patients, Surgery+LEX-IORT; Group D: 21 patients, Surgery+postoperative chemotherapy and external irradiation. Subgroup analysis showed that increased chemotherapy extended survival compared with surgery alone (median OS: 7 months vs 11 months, p=0.0002). In addition to chemotherapy, LEX-IORT significantly improved PFS ( 8 months vs 11.5 months, p=0.0061) and OS ( 11 months vs 16.5 months, p=0.0113). Increasing EBRT did not improve outcomes. Summary: Surgical resection combined with LEX-IORT and postoperative chemotherapy can increase the local control rate, significantly prolong the survival of patients, and does not increase the incidence of related complications and adverse reactions.
What problem does this paper attempt to address?